Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/15/2005US6965034 Deoxygenation of epothilone A or B, to form desoxyepothilone used as nontoxic anticarcinogenic agents
11/15/2005US6965033 Bisamidate phosphonate prodrugs
11/15/2005US6965032 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates and their preparation and use
11/15/2005US6965027 Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate
11/15/2005US6965005 Mold inhibitor integrated within a matrix and method of making same
11/15/2005US6964984 Preventing desensitization of receptors
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964982 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
11/15/2005US6964981 Therapeutic treatment or prevention of physiological disorders associated with an excess of tachykinins, with neurokinin 1 (NK-1) receptor antagonists; a 2-phenyl-2-(3-phenyl-tetrahydrofuran-2-yloxy)- ethanol
11/15/2005US6964980 Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
11/15/2005US6964979 Liver disorders
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964977 E.g., 5-(((Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-amino)-1,3-dihydro-2H -benzimidazol-2-one; inhibition or antagonism of protein kinases; treating pain or cancer
11/15/2005US6964976 Amino alcohol derivatives
11/15/2005US6964974 2,3-oxidosqualene-lanosterol cyclase inhibitors
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005US6964972 8-Azabicyclo(3,2,1)oct-2 ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/15/2005US6964971 Oral administering; sustained release
11/15/2005US6964970 Heterocyclic amines such as 2-benzoyl-1,3,4,9-tetrahydro-2H-pyrido(3,4-b)indole, used preferential inhibitors of fatty acid biosynthesis in bacterial systems; bactericides
11/15/2005US6964969 Composition and method for treating impaired or deteriorating neurological function
11/15/2005US6964968 Respiratory system disorders; cardiovascular disorders; viricides
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964966 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/15/2005US6964964 Anticancer agents
11/15/2005US6964962 A norepinephrine reuptake inhibitor or its salt and a neuroleptic agent
11/15/2005US6964961 Antiproliferative agents for mammals
11/15/2005US6964960 Indoloquinazolinones
11/15/2005US6964959 Use of a methylol-containing compound to treat tumors
11/15/2005US6964958 Benzodiazepine-3-carboxamide derviatives
11/15/2005US6964957 For use in therapy of neurodegenerative diseases and certain cancers
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/15/2005US6964955 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
11/15/2005US6964954 Use of DHEA derivatives on keratinous substances
11/15/2005US6964953 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
11/15/2005US6964952 Mixture of lipid and carrier; topical applying to skins
11/15/2005US6964950 Oligonucleotides which hybridize with nucleic acids which encode said protein; gene therapy; genetic engineering; for treatment of angina and myocardial infarction
11/15/2005US6964949 Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
11/15/2005US6964946 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
11/15/2005US6964785 Herbal composition for improving anticancer activity, immune response and hematopoiesis of the body, and protecting the body from oxidative damage, and the method of preparing the same
11/15/2005US6964784 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
11/15/2005US6964783 Non-solid composition for local application
11/15/2005US6964782 Stable hydrogen peroxide compositions, products and methods of use
11/15/2005US6964781 For delivering drug directly to the interior portions of the body of a mammalian organism, such as to the eye
11/15/2005US6964780 Phosphodiesterase inhibitor; therapy for sexual disorders; sildenafil in polyoxyethylene glycol enteric coating
11/15/2005US6964777 An antianxiety agent such as buspirone; a dermal penetration enhancer of given formula such as octyl salicylate; and a volatile liquid such as ethanol
11/15/2005US6964776 For therapy of hyperpigmentation and vitiligo
11/15/2005US6964772 Chitosan-xanthan based polyionic hydrogels for stabilization and controlled release of vitamins
11/15/2005US6964761 Administering and depositing interferon in the lungs; for patients are unresponsive to treatment with corticosteroid, cyclophosphamide, and azathioprine; therapeutic dosage pluse immunosuppressant or antiinflammatory agent; drug delivery
11/15/2005US6964759 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
11/15/2005CA2433190C Amlodipine hemimaleate
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2357833C Treatment of pulmonary hypertension using vasopressin antagonist
11/15/2005CA2352190C Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
11/15/2005CA2343148C Quick release pharmaceutical compositions of drug substances
11/15/2005CA2330351C New linear or cyclical ureas, their preparation process and the pharmaceutical compositions which contain them
11/15/2005CA2311988C Crystalline oxathiolane derivatives
11/15/2005CA2296637C Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containingit
11/15/2005CA2250191C Benzothiophenes, formulations containing same, and methods
11/15/2005CA2248802C Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same
11/15/2005CA2235617C Therapeutic preparation for the transdermal administration of active substances
11/15/2005CA2207627C 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
11/15/2005CA2198875C Quinazolinone pharmaceuticals and use thereof
11/15/2005CA2179640C Watersoluble azole antifungals
11/15/2005CA2179419C Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds
11/15/2005CA2172401C Transdermal therapeutic system with acetylsalicylic acid as active substance
11/15/2005CA2164847C O6-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells
11/15/2005CA2130944C Ortho-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/2005CA2130031C Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/2005CA2111512C 3,5-substituted aminobenzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
11/15/2005CA2070120C Thioxanthenone antitumor agents
11/14/2005CA2467329A1 Inner core lps epitopes and uses thereof
11/14/2005CA2467321A1 Polymeric coupling agents and pharmaceutically-active polymers made therefrom
11/13/2005CA2507567A1 Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions
11/13/2005CA2507348A1 Real time methylumbelliferone-based assay
11/10/2005WO2005106495A1 Procollagen ii biomarkers and methods
11/10/2005WO2005106473A1 Method of screening therapeutic agent for neurodegenerative disease
11/10/2005WO2005106459A1 Method of determining ability of drug to bind to troponin i and test drug for the determination
11/10/2005WO2005106007A1 Labeling of rapamycin using rapamycin-specific methylases
11/10/2005WO2005105998A1 HUMAN ANTIAMYLOID β PEPTIDE ANTIBODY AND ANTIBODY FRAGMENT THEREOF
11/10/2005WO2005105995A2 RNA INTERFERENCE MEDIATED TREATMENT OF POLYGLUTAMINE (POLYQ) REPEAT EXPANSION DISEASES USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/10/2005WO2005105886A1 Low molecular weight polylactic acid polymers
11/10/2005WO2005105852A1 Novel arabinogalactan, substance with antidiabetic activity and method of use thereof
11/10/2005WO2005105833A2 Novel herpes simplex viruses and uses thereof
11/10/2005WO2005105823A1 Steroid derivatives
11/10/2005WO2005105817A2 Coupling process for generating reactive boron­ containing derivatives of n-substituted pyrrole-2­ carbonitriles to produce biaryls
11/10/2005WO2005105809A1 Thienopyridines as ikk inhibitors
11/10/2005WO2005105808A1 Thienopyridazines as ikk inhibitors
11/10/2005WO2005105807A1 Process for producing pentacyclic taxane
11/10/2005WO2005105806A1 Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
11/10/2005WO2005105805A1 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof
11/10/2005WO2005105804A1 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR PRODUCTION THE ACTIVE AGENT
11/10/2005WO2005105803A2 Purine derivatives as a1 adenosine receptor antagonists
11/10/2005WO2005105801A1 Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents
11/10/2005WO2005105793A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
11/10/2005WO2005105790A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
11/10/2005WO2005105788A1 Indole derivatives and use thereof as kinase inhibitors
11/10/2005WO2005105787A1 Rapid and robust 3d/3d registration technique
11/10/2005WO2005105781A1 Imidazole derivatives used as tafia inhibitors
11/10/2005WO2005105780A2 Compositions useful as inhibitors of rock and other protein kinases
1 ... 4470 4471 4472 4473 4474 4475 4476 4477 4478 4479 4480 4481 4482 4483 4484 4485 4486 4487 4488 4489 4490 ... 7860